Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis, Chronic

Clinical trial condition

Hepatitis, Chronic

Explore clinical trials studying Hepatitis, Chronic. Study availability and eligibility vary by location and protocol.

1,281 public trials 89 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis, Chronic trial results

Completed

A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection

NCT02292719

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus Infection, +15 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate Chronic Hepatitis C Infection

NCT01716585

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Infection, +15 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis

NCT02219503

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Infection, +16 more
Locations: Not specified

View Trial Details

Completed

A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection

NCT01939197

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chronic Disease, +29 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1a Infection

NCT01833533

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Infection, +15 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis

NCT01704755

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Infection, +17 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)

NCT01995071

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +18 more
Locations: Not specified

View Trial Details

Completed

Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6

NCT03303599

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Klinikum Klagenfurt am Woerthersee, Apotheke /ID# 169931 Klagenfurt, Carinthia, Austria

University Hospital St. Polten /ID# 169918 Sankt Pölten, Lower Austria, Austria

Medizinische Universität Graz /ID# 169932 Graz, Styria, Austria

Landeskrankenhaus Hall /ID# 169930 Hall in Tirol, Tyrol, Austria

View all 156 locations

View Trial Details

Completed

Role of Pegylated Interferon in Combination With DAAs to Cure Hepatitis C As Soon As Possible - Hepatitis C [ASAP-C]

NCT03480932

Conditions: Behavior, Blood-Borne Infections, Chronic Disease, +21 more
Locations: YR Gaitonde Centre for AIDS Education and Johns Hopkins University Collaborative Integrated Care Center (YRG-JHU ICC) Bilāspur, Chhattisgarh, India

View Trial Details

Completed

A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic

NCT03235154

Conditions: Blood-Borne Infections, Chemically-Induced Disorders, Chronic Disease, +20 more
Locations: Cambridge Health Alliance Outpatient Addiction Services Somerville, Massachusetts, United States

View Trial Details